Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026)

Cresco Labs' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $66.1 million for Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 8.87% year-over-year to $66.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.1 million (down 8.87% YoY) and the FY2025 annual result came in at $71.6 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability was $66.1 million for Q1 2026 at Cresco Labs, down from $71.6 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $84.2 million in Q1 2022 and bottomed at $40.5 million in Q4 2023.
• A 5-year average of $64.6 million and a median of $72.6 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 93.39% — and 2023, when it tumbled 46.16%.
• Cresco Labs' Non-Current Deferred Tax Liability stood at $75.1 million in 2022, then tumbled by 46.16% to $40.5 million in 2023, then rose by 1.06% to $40.9 million in 2024, then soared by 75.12% to $71.6 million in 2025, then fell by 7.66% to $66.1 million in 2026.
• Business Quant data shows CRLBF's Non-Current Deferred Tax Liability at $66.1 million in Q1 2026, $71.6 million in Q4 2025, and $72.6 million in Q3 2025.